237 related articles for article (PubMed ID: 28729120)
1. Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
Koniarczyk HL; Ferraro C; Miceli T
Semin Oncol Nurs; 2017 Aug; 33(3):265-278. PubMed ID: 28729120
[TBL] [Abstract][Full Text] [Related]
2. Clinical updates in blood and marrow transplantation in multiple myeloma.
Faiman B; Miceli T; Noonan K; Lilleby K
Clin J Oncol Nurs; 2013 Dec; 17 Suppl():33-41. PubMed ID: 24280457
[TBL] [Abstract][Full Text] [Related]
3. Autologous hematopoietic stem cell transplantation for patients with multiple myeloma: an overview for nurses in community practice.
Miceli T; Lilleby K; Noonan K; Kurtin S; Faiman B; Mangan PA
Clin J Oncol Nurs; 2013 Dec; 17 Suppl():13-24. PubMed ID: 24280455
[TBL] [Abstract][Full Text] [Related]
4. The changing landscape of multiple myeloma: implications for oncology nurses.
Kurtin S; Faiman B
Clin J Oncol Nurs; 2013 Dec; 17 Suppl():7-11. PubMed ID: 24280454
[TBL] [Abstract][Full Text] [Related]
5. History of hematopoietic stem cell transplantation.
Ezzone SA
Semin Oncol Nurs; 2009 May; 25(2):95-9. PubMed ID: 19411011
[TBL] [Abstract][Full Text] [Related]
6. [Allogeneic hematopoietic stem cell transplantation for multiple myeloma].
Takase K; Miyamoto T
Nihon Rinsho; 2015 Jan; 73(1):107-13. PubMed ID: 25626314
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic stem cell transplantation for multiple myeloma: curative but not the standard of care.
Koehne G; Giralt S
Curr Opin Oncol; 2012 Nov; 24(6):720-6. PubMed ID: 22960558
[TBL] [Abstract][Full Text] [Related]
8. Autologous hematopoietic stem cell transplantation for multiple myeloma: frequently asked questions.
Mangan PA; Gleason CL; Miceli T
Clin J Oncol Nurs; 2013 Dec; 17 Suppl():43-7. PubMed ID: 24280458
[TBL] [Abstract][Full Text] [Related]
9. International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation.
Palumbo A; Sezer O; Kyle R; Miguel JS; Orlowski RZ; Moreau P; Niesvizky R; Morgan G; Comenzo R; Sonneveld P; Kumar S; Hajek R; Giralt S; Bringhen S; Anderson KC; Richardson PG; Cavo M; Davies F; Bladé J; Einsele H; Dimopoulos MA; Spencer A; Dispenzieri A; Reiman T; Shimizu K; Lee JH; Attal M; Boccadoro M; Mateos M; Chen W; Ludwig H; Joshua D; Chim J; Hungria V; Turesson I; Durie BG; Lonial S;
Leukemia; 2009 Oct; 23(10):1716-30. PubMed ID: 19494840
[TBL] [Abstract][Full Text] [Related]
10. Psychoneuroimmunology in multiple myeloma and autologous hematopoietic stem cell transplant: Opportunities for research among patients and caregivers.
Christian LM; Kiecolt-Glaser JK; Cole SW; Burd CE; Madison AA; Wilson SJ; Rosko AE
Brain Behav Immun; 2024 Jul; 119():507-519. PubMed ID: 38643954
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and survival of 338 multiple myeloma patients treated with hematopoietic stem cell transplantation or conventional chemotherapy.
Pérez R; Durán MS; Mayans J; Soler A; Castillo I; Jurado M; Ribas P; Menchaca Echevarria MC; Hernandez MT; Lopez Garcia-Carreño MD; Echeveste Gutierrez A; Bailen Garcia A; Lopez S; Baquero J; Ramirez G
Eur J Haematol; 2016 Apr; 96(4):417-24. PubMed ID: 26190662
[TBL] [Abstract][Full Text] [Related]
12. Current status of autologous hematopoietic stem cell transplantation in myeloma.
Mehta J; Singhal S
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S28-S34. PubMed ID: 18724294
[TBL] [Abstract][Full Text] [Related]
13. [The importance of autologous transplantation in multiple myeloma].
Pour L; Hájek R; Adam Z; Krejcí M; Vorlícek J
Vnitr Lek; 2009 Sep; 55(9):767-72. PubMed ID: 19785373
[TBL] [Abstract][Full Text] [Related]
14. Incidence of infection according to intravenous immunoglobulin use in autologous hematopoietic stem cell transplant recipients with multiple myeloma.
Park S; Jung CW; Jang JH; Kim SJ; Kim WS; Kim K
Transpl Infect Dis; 2015 Oct; 17(5):679-87. PubMed ID: 26201517
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell transplantation in multiple myeloma.
Pant S; Copelan EA
Biol Blood Marrow Transplant; 2007 Aug; 13(8):877-85. PubMed ID: 17640590
[TBL] [Abstract][Full Text] [Related]
16. Expanding indications for stem cell transplantation.
Schmit-Pokorny K
Semin Oncol Nurs; 2009 May; 25(2):105-14. PubMed ID: 19411013
[TBL] [Abstract][Full Text] [Related]
17. Reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma: a concise review.
Salit RB; Bishop MR
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):247-52. PubMed ID: 21658650
[TBL] [Abstract][Full Text] [Related]
18. [Observation of humoral immunity reconstitution and its relationship with infection after autologous hematopoietic stem cell transplantation for patients with multiple myeloma].
Liu JR; Li J; Shang JJ; Zheng D; Gu JL; Zou WY; Xu DR
Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):317-22. PubMed ID: 23668204
[TBL] [Abstract][Full Text] [Related]
19. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
Kyle RA
Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
[TBL] [Abstract][Full Text] [Related]
20. Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome.
Zeiser R; Deschler B; Bertz H; Finke J; Engelhardt M
Bone Marrow Transplant; 2004 Dec; 34(12):1057-65. PubMed ID: 15516937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
